Pub Date : 2018-08-02DOI: 10.25270/JCP.2018.08.00029
A. Christodoulopoulou, B. Bach, A. Klink, G. Hechmati, U. Mujumdar, B. Feinberg, M. Fakih
{"title":"KRAS/RAS Testing Is Associated With Reduced Risk of Treatment Discontinuation in Patients With Metastatic Colorectal Cancer","authors":"A. Christodoulopoulou, B. Bach, A. Klink, G. Hechmati, U. Mujumdar, B. Feinberg, M. Fakih","doi":"10.25270/JCP.2018.08.00029","DOIUrl":"https://doi.org/10.25270/JCP.2018.08.00029","url":null,"abstract":"","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83695632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-06-12DOI: 10.25270/JCP.2018.06.00025
Rebecca A. Kirch, C. Donovan, Alan Balch
{"title":"Palliative Care: The “Miracle Drug” Still Missing in Many Clinical Pathways","authors":"Rebecca A. Kirch, C. Donovan, Alan Balch","doi":"10.25270/JCP.2018.06.00025","DOIUrl":"https://doi.org/10.25270/JCP.2018.06.00025","url":null,"abstract":"","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75167199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-06-12DOI: 10.25270/jcp.2018.06.00020
Amy Schroeder
{"title":"How Oncology Care Decision-Makers Define Clinical Pathway Programs: Conceptual vs Reported Definitions","authors":"Amy Schroeder","doi":"10.25270/jcp.2018.06.00020","DOIUrl":"https://doi.org/10.25270/jcp.2018.06.00020","url":null,"abstract":"","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"401 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79678928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-06-12DOI: 10.25270/jcp.2018.06.00023
R. Stefanacci
{"title":"Understanding the “American Patient First” Blueprint: Implications for Clinical Pathways","authors":"R. Stefanacci","doi":"10.25270/jcp.2018.06.00023","DOIUrl":"https://doi.org/10.25270/jcp.2018.06.00023","url":null,"abstract":"","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"1981 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87800473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-06-12DOI: 10.25270/JCP.2018.06.00022
B. Naydeck
{"title":"Difficulties of Implementing Value-Based Insurance Design","authors":"B. Naydeck","doi":"10.25270/JCP.2018.06.00022","DOIUrl":"https://doi.org/10.25270/JCP.2018.06.00022","url":null,"abstract":"","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88906101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-06-12DOI: 10.25270/JCP.2018.06.00024
M. Linthicum, J. Bright, J. Shafrin
{"title":"Open-Source Tools for Value Assessment: A Promising Approach","authors":"M. Linthicum, J. Bright, J. Shafrin","doi":"10.25270/JCP.2018.06.00024","DOIUrl":"https://doi.org/10.25270/JCP.2018.06.00024","url":null,"abstract":"","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"57 2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83554618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-06-12DOI: 10.25270/JCP.2018.06.00026
A. Brufsky, S. Raychaudhuri
{"title":"Value of New HER2+ Breast Cancer Therapies","authors":"A. Brufsky, S. Raychaudhuri","doi":"10.25270/JCP.2018.06.00026","DOIUrl":"https://doi.org/10.25270/JCP.2018.06.00026","url":null,"abstract":"","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74921040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-06-12DOI: 10.25270/JCP.2018.06.00021
Ira M Klein
{"title":"Why We Really Do Value-Based Contracting","authors":"Ira M Klein","doi":"10.25270/JCP.2018.06.00021","DOIUrl":"https://doi.org/10.25270/JCP.2018.06.00021","url":null,"abstract":"","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"398 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74962738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-05-01DOI: 10.1016/J.JVAL.2018.04.819
Y. Koleva, L. Abbrecht, J. Yeo, Chenguang Zhang, H. Safah, N. Saba
{"title":"Impact of Psychosocial Factors on Health Services Utilization and Cost of Care in Blood and Marrow Transplant Patients","authors":"Y. Koleva, L. Abbrecht, J. Yeo, Chenguang Zhang, H. Safah, N. Saba","doi":"10.1016/J.JVAL.2018.04.819","DOIUrl":"https://doi.org/10.1016/J.JVAL.2018.04.819","url":null,"abstract":"","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75287145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.25270/jcp.2018.02.00001
Casey Mason, Peter G Ellis, Kathy Lokay, Amanda Barry, Natalie Dickson, Ray Page, Blase Polite, Ravi Salgia, Michael Savin, Corey Shamah, Mark A Socinski
Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non-small cell lung cancer (NSCLC), there is evidence that testing has not been widely embraced in the clinical setting. This study uses clinical pathways to understand biomarker testing patterns and ensuing first-line treatment decisions. Data of patients with metastatic NSCLC were analyzed for testing rates and treatment selection at 7 cancer programs using data input by providers into the pathways software. Findings were analyzed by type of provider (community or academic). Among providers using clinical pathways, biomarker testing rates were high and appropriate selection of targeted therapy was observed. Clinical pathways can act as a tool to assist oncology practices to promote testing of key biomarkers and subsequent selection of appropriate therapy.
{"title":"Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting.","authors":"Casey Mason, Peter G Ellis, Kathy Lokay, Amanda Barry, Natalie Dickson, Ray Page, Blase Polite, Ravi Salgia, Michael Savin, Corey Shamah, Mark A Socinski","doi":"10.25270/jcp.2018.02.00001","DOIUrl":"https://doi.org/10.25270/jcp.2018.02.00001","url":null,"abstract":"<p><p>Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non-small cell lung cancer (NSCLC), there is evidence that testing has not been widely embraced in the clinical setting. This study uses clinical pathways to understand biomarker testing patterns and ensuing first-line treatment decisions. Data of patients with metastatic NSCLC were analyzed for testing rates and treatment selection at 7 cancer programs using data input by providers into the pathways software. Findings were analyzed by type of provider (community or academic). Among providers using clinical pathways, biomarker testing rates were high and appropriate selection of targeted therapy was observed. Clinical pathways can act as a tool to assist oncology practices to promote testing of key biomarkers and subsequent selection of appropriate therapy.</p>","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"4 1","pages":"49-54"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709712/pdf/nihms-1044068.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41222230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号